340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

ACA Expands 340B Eligibility but Also Puts Squeeze on Hospitals

 

Some critics of the 340B drug discount program say it should be phased out because millions of people will get health coverage under health care reform. This argument ignores that other parts of the Affordable Care Act (ACA) are squeezing public and private nonprofit hospitals' finances—making hospitals' continued access to 340B drug discounts more important than … [Read more...]

AIDS Group Files Second Suit Alleging 340B Overcharges

Says Johnson & Johnson wrongly denied it up to $2 million in discounts 

November 1, 2013—The AIDS Healthcare Foundation (AHF) has filed suit in California against drug manufacturer Johnson & Johnson (J&J) and its Janssen Therapeutics and Janssen Biotech units to recover as much as $2 million in 340B drug discounts that it claims the family of companies failed to provide it between 2005 and 2012. … [Read more...]

Medicare Outpatient Payment Final Rule Delayed Due to Sequester

In July, CMS proposed continuing ASP plus 6% rate for specified high-cost drugs 

October 31, 2013—Final regulations setting next year's Medicare reimbursement rates for hospital outpatient services and specified high-cost drugs will be held up for about a month due to the recent partial government shutdown. … [Read more...]

Judge Agrees to Speed Up 340B Orphan Drug Lawsuit

All filings in advance of hearing are due by Jan. 17 

October 31, 2013—A federal district judge has approved the federal government's and drug manufacturers' joint motion to speed up the industry’s lawsuit challenging the legality of the 340B orphan drug exclusion regulation. … [Read more...]

PhRMA and HHS Want to Resolve 340B Orphan Drug Suit Quickly

If judge agrees, ruling on the merits of industry's arguments could come as soon as January 

October 24, 2013—The federal government and drug manufacturers have agreed to fast-track the industry's lawsuit challenging the legality of the 340B orphan drug exclusion regulation. … [Read more...]

Investor’s Business Daily Publishes Our Defense of 340B

 

Investor's Business Daily (IBD) recently published a diatribe against 340B hospitals and the 340B program by Sally C. Pipes, who heads the "think tank" Pacific Research Institute. Among other fulminations, Pipes said 340B is an "ungainly operation fattening the bottom lines of pharmacies and hospitals," "fails to actually help vulnerable patients," and "represents an … [Read more...]

RAND Corp. Launches 340B Research Project

Leaders say they aim to provide objective, nonpartisan analysis 

October 22, 2013—The RAND Corp. announced yesterday that it is launching a project to study and make recommendations for improving the 340B program. Organizers said one of their first tasks will be to submit comments on forthcoming 340B regulations due to be published in the coming months. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health